Cherry Tree Wealth Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$441 Sell
20
-56
-74% -$975 ﹤0.01% 564
2025
Q4
$897 Hold
76
﹤0.01% 545
2025
Q3
$1.2K Hold
76
﹤0.01% 536
2025
Q2
$871 Hold
76
﹤0.01% 560
2025
Q1
$1.03K Sell
76
-228
-75% -$3.79K ﹤0.01% 677
2024
Q4
$5.14K Hold
304
﹤0.01% 471
2024
Q3
$6.18K Hold
304
﹤0.01% 464
2024
Q2
$6.86K Hold
304
﹤0.01% 440
2024
Q1
$7.98K Hold
304
﹤0.01% 400
2023
Q4
$9.59K Hold
304
﹤0.01% 357
2023
Q3
$8.53K Hold
304
﹤0.01% 351
2023
Q2
$11.2K Buy
+304
New +$9.28K ﹤0.01% 330

Other funds holding CC

Cherry Tree Wealth Management's CC Position: Q1 2026 in Review

Cherry Tree Wealth Management reduced its Chemours (CC) stake by 74% in Q1 2026, selling an estimated $975 and leaving 20 shares worth $441. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Cherry Tree Wealth Management first reported a position in CC in Q2 2023 and has held it in 12 quarters since. The position peaked at $11.2K in Q2 2023. 450 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Cherry Tree Wealth Management held 20 shares of Chemours worth $441 as of Q1 2026.
  • Cherry Tree Wealth Management sold 56 Chemours shares in Q1 2026, an estimated $975.
  • Chemours made up ﹤0.01% of Cherry Tree Wealth Management's portfolio in Q1 2026, its #564 holding.
  • Cherry Tree Wealth Management first reported a position in Chemours in Q2 2023 and has held it in 12 quarters since.
  • Cherry Tree Wealth Management's Chemours position peaked at $11.2K in Q2 2023.
  • 450 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.